APOL1 and focal segmental glomerulosclerosis: Most compellingly, the almost 50% amelioration of proteinuria in FSGS patients by VX-147 overwhelmingly supports cation channel activity as the major role of APOL1 in AMKD5, assuming it prolongs kidney function in the ongoing placebo-controlled phase II/III study (NCT05312879).